drugset / Trial / NCT01541891

Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome

NCT01541891

Phase 2 Completed 30 enrolled Laboratorios Sophia S.A de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of PRO-148 ophthalmic solution compared with SYSTANE ® ophthalmic solution for the treatment of signs and symptoms of mild-to-moderate dry eye syndrome.

Timeline

Start
2011-10
Primary completion
2012-03
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PRO-148 Unknown Other
Comparator Systane Other / unclassified Other

Indications